All News

The study will evaluate the safety, tolerability, and efficacy of the in combination in patients both with and without prior exposure to a KRASG12C inhibitor.

As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is.

At month 6 post-COVID-19 infection, 123 patients received a diagnosis of type 1 diabetes (T1D) and only 72 were diagnosed with T1D at 6 months post-non-COVID-19 respiratory infection.

New treatments for chronic migraine have been increasing, with robust evidence for eptinezumab, erenumab, fremanezumab, galcanezumab, and onabotulinumtoxin A.

The process of supporting a cause for our profession can be highly rewarding. As pharmacists, we must take charge to enact change.

Investigators found that lifestyle changes such as a high-quality diet and regular exercise can lower the risk of type 2 diabetes in women with a history of gestational diabetes mellitus.

The drug shows improvement in exercise capacity and key secondary outcomes compared with the placebo when added to background therapy for those with pulmonary arterial hypertension.

Investigators found that 25% of patients with heart failure with reduced ejection fraction received guideline-recommended intravenous fluids compared to 37% who did not have the condition.

Keynote speaker at the AMCP Nexus conference discusses recent FDA approvals and those scheduled over the next year.

In the trial, randomized patients with UC who received corticosteroids at maintenance baseline were able to eliminate the use of corticosteroids by week 200.

Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.

Opportunities for further optimization of CML management remain.

New research suggests that ketamine can help rehabilitate those who suffer from an eating disorder, and it is important to recognize the root cause of this mental health crisis.

As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is.

The availability of bivalent mRNA COVID-19 boosters, which provide broader protection, will likely increase vaccine demand in the fall

Panelists at the AMCP Nexus conference share tips on new opportunities for students and career-changers looking to forge a new path.

Panelists at the AMCP Nexus conference discuss the burden of undertreated and untreated chronic kidney disease.

Zanubrutinib (Brukinsa) is a small molecule Bruton’s tyrosine kinase inhibitor under evaluation as a monotherapy and in combination with other treatments for various B-cell malignancies.

Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.

The specialty pharmacy space can tie into public health populations through many different initiatives.

Pharmacists are poised to address selective vaccination and counsel patients contemplating delaying, skipping, or seeking an alternate vaccine schedule.

Heidi D. Finnes, PharmD, BCOP, FHOPA, president of HOPA discusses some key recommendations to women interested in pursuing leadership roles in oncology pharmacy.

The Moderna bivalent vaccine is authorized for children 6 years of age and older, and the Pfizer-BioNTech vaccine is authorized for children 5 years of age and older.

Treating patients with rivaroxaban resulted in 32.5 fewer symptomatic venous thromboembolism (VTE) and VTE-related deaths among 10,000 patients.

The VEGA study is the first randomized, controlled trial to evaluate the efficacy and safety of combination therapy with an interleukin (IL)-23p19 subunit antagonist (guselkumab) and a tumor necrosis factor-alpha (TNFα) antagonist (golimumab) in UC.

Investigators find that individuals with both conditions are more likely to develop severe disease than those in the control group.

A researcher suggests that understanding specific cell function in the tumor microenvironment can help create effective and individualized immunotherapy cancer treatments.

Deciding what goods to sell and how to arrange them will dictate the patient’s interactivity and experience.

Eliminating paper prescriptions allows for greater legibility, security, trackability for pharmacists and providers.

Omidubicel is a stem cell-based product that utilizes nicotinamide to inhibit differentiation and to increase the migration, bone marrow homing, and engraftment efficiency of hematopoietic progenitor cells.